Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.03 | 0.7 |
mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.11 | 0.7 |
mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |